THE WOODLANDS, Texas--(BUSINESS WIRE)-- <\/p>\n
MolecularHealth announced today that it is a bronze-level supporter of the 9th Annual Personalized Medicine Conference, being hosted this week by the Partners HealthCare Center for Personalized Medicine (PCPGM) at Harvard Medical School in Boston. Representatives of the company, including CEO Lloyd Everson, M.D., and Chairman of the Board Friedrich von Bohlen, Ph.D., will attend the conference. <\/p>\n
This conference is one of the most important events of the year for those of us involved in personalized medicine, said Dr. Everson. MolecularHealths goal is to provide personalized, precision treatment support to cancer patients and their medical teams, which aligns perfectly with the PCPGMs mission to accelerate the integration of genetic knowledge into clinical care. <\/p>\n
MolecularHealth will offer an end-to-end service that supports healthcare providers and their patients through the molecular diagnostic processcollecting tumor samples, analyzing the samples, and interpreting the results using a proprietary analytics platformall to generate safer, personalized cancer treatment choices. The company is backed by Dietmar Hopp, co-founder and former chairman and CEO of SAP. <\/p>\n
ABOUT MOLECULARHEALTH <\/p>\n
MolecularHealth delivers on the promise of personalized, precision medicine. By using advanced proprietary information technologies to sift through terabytes of genetic and molecular test findings in a fraction of the time needed for current manual analysis, MolecularHealth provides doctors and patients with faster, more accurate insights into the role genes play in the progression and treatment of an individuals cancer. Eight years in development by a multidisciplinary team of doctors, scientists and IT experts, MolecularHealth works in partnership with some of the worlds leading healthcare and information technology companies, including the University of Texas MD Anderson Cancer Center, SAP AG, and the U.S. Food and Drug Administration (FDA). The company has headquarters in The Woodlands, Texas; Basel, Switzerland; and Heidelberg, Germany. Visitwww.molecularhealth.comfor more information. <\/p>\n
<\/p>\n
See the rest here: <\/p>\n
MolecularHealth Sponsors Harvard Personalized Medicine Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" THE WOODLANDS, Texas--(BUSINESS WIRE)-- MolecularHealth announced today that it is a bronze-level supporter of the 9th Annual Personalized Medicine Conference, being hosted this week by the Partners HealthCare Center for Personalized Medicine (PCPGM) at Harvard Medical School in Boston. Representatives of the company, including CEO Lloyd Everson, M.D., and Chairman of the Board Friedrich von Bohlen, Ph.D., will attend the conference. Continue reading